Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells

Imiquimod (IMQ), a synthetic agonist to Toll-like receptor (TLR) 7, is being successfully used for the treatment of certain skin neoplasms, but the exact mechanisms by which this compound induces tumor regression are not yet understood. While treating basal cell carcinoma (BCC) patients with topical...

Descripción completa

Detalles Bibliográficos
Autores principales: Stary, Georg, Bangert, Christine, Tauber, Martina, Strohal, Robert, Kopp, Tamara, Stingl, Georg
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2007
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118597/
https://www.ncbi.nlm.nih.gov/pubmed/17535975
http://dx.doi.org/10.1084/jem.20070021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118597/
https://www.ncbi.nlm.nih.gov/pubmed/17535975
http://dx.doi.org/10.1084/jem.20070021

Ejemplares similares